Aspire Indiana Health is a licensed substance use treatment provider in Indianapolis, IN, listed in the SAMHSA treatment directory. Long term residential treatment is available for people who need more than a short stay. An intensive outpatient program lets clients attend structured treatment several days a week while living at home. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The facility reports accepting Medicaid. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Substance use treatmentTransitional housing, halfway house, or sober home
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
Federal, or any government funding for substance use treatment programsMedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than MedicaidSAMHSA funding/block grants
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState mental health departmentThe Joint CommissionFederally Qualified Health Center
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicaid
927 North Pennsylvania Street, Indianapolis, IN 46202
Hospital inpatient/24-hour hospital inpatientResidential/24-hour residentialHospital inpatient treatmentFederal, or any government funding for substance use treatment programsMedicaid
611 North Capitol Avenue, 2nd Floor, Indianapolis, IN 46204
Hospital inpatient/24-hour hospital inpatientResidential/24-hour residentialHospital inpatient treatmentFederal, or any government funding for substance use treatment programsMedicaid